
Valitse etikettisi
näkyy suoraan injektiopullossaGlow Blend (Mini)
Healing
- Lähetetään Saksasta
Tilaus
- DHL seurannalla
- Huomaamaton pakkaus
Yhdellä silmäyksellä
Glow Blend (Mini) lukuina
Tietopankkimme keskeiset luvut.
Koko tietopankkiartikkeli- Class
- Healing/beauty blend
- Use
- Subcutaneousin mg
- Sizes
- 50 mg1 size in the shop
What studies show
All 3 sources in the lexicon- Crockford et al., Annals of the New York Academy of Sciences, 2010
Randomised trial of GHK-Cu gel in diabetic foot ulcers (opens in a new tab)
Mulder et al., Wound Repair and Regeneration, 1994- Malinda et al., Journal of Investigative Dermatology, 1999
Arvostelut
Mitä asiakkaat sanovat
Vain todelliset tilaukset, joissa oli Glow Blend (Mini).
Kaikki arvostelutTuotteelle Glow Blend (Mini) ei ole vielä laboratorioanalyysia. Äänestä sitäTestauta itse, me maksamme puoletKaikki laboratorioanalyysit
Tietoa
Kaikki aiheesta Glow Blend (Mini)
Tarkemmat tiedot tulossa pian.
Annostelu
Ladataan annostelutietoja …
Tilaa samalla
Mitä tarvitset sen kanssa
Bakteriostaattinen vesi lisätään ostoskoriisi automaattisesti. Ruiskut ja pyyhkeet yhdellä napsautuksella.
Insuliiniruiskut
10 kpl · 5.50 €
Alkoholipyyhkeet
50 kpl · 10 €
Kuinka paljon vettä?
Ruiskun yksiköt injektiopullosi koolle.
Avaa laskuri →Are there studies on the Glow Blend?
No. As of 26 October 2026 there is no study on the ready-made blend, neither on ClinicalTrials.gov nor in PubMed. All three compounds together only appear in reviews. The components have been studied, almost always each on its own.
What is the difference from the large Glow Blend?
It is the same mix of BPC-157, TB-500 and GHK-Cu, just in a smaller vial. The evidence is identical for both, since only the single components have been studied.
Is the combination stronger than the single compounds?
That has not been studied. In the only study with two of the three components (tendon healing in rats), BPC-157 plus TB-500 gave no advantage over either compound alone. The authors suspect that both act on shared pathways. There are no data on GHK-Cu in combination.
How well has BPC-157 been studied in humans?
Barely. A systematic review found 36 studies: 35 in animals or cells and one retrospective analysis of 12 people with knee pain. A second review from 2026 counted three small human studies with 30 people in total and rated the evidence as very low.
Is TB-500 the same as thymosin beta-4?
Not quite. TB-500 is described as a fragment of thymosin beta-4. The studies, including the wound healing in rats and the phase 1 trial into a vein, used full thymosin beta-4. We found no study with TB-500 itself.
Which side effects are known?
There are no data for the blend. The three small BPC-157 human studies reported no treatment-related side effects. Thymosin beta-4 was well tolerated in a phase 1 trial into a vein. Solid long-term data are missing for all three. Reviews also warn about contamination from unregulated manufacturing.
Is the Glow Blend approved?
No. Neither the blend nor any of the three components is approved as a medicine (as of October 2026). The least studied are BPC-157 (phase 1 as the highest phase in ChEMBL) and GHK-Cu (only an early phase 1 trial in the registry), which is why phase 1 is shown as the stage here.
Liittyvät
Samankaltaiset tuotteet
BPC-157
Peptidit · Paraneminen ja palautuminen Paraneminen ja palautuminen
4 kokoa
Laboratoriotestattu
= alkaen 5.2 €/injektiopullo
TB-500 (Thymosin B4)
Peptidit · Paraneminen ja palautuminen Paraneminen ja palautuminen
3 kokoa
Laboratoriotestattu
= alkaen 18.8 €/injektiopullo
TB-500 FRAG
Peptidit · Paraneminen ja palautuminen Paraneminen ja palautuminen
1 koko
= 24.8 €/injektiopullo
BPC + TB Blend
Peptidit · Paraneminen ja palautuminen Paraneminen ja palautuminen
3 kokoa
Laboratoriotestattu
= alkaen 24.8 €/injektiopullo
Glow Blend (Mini)